Related Experiment Video
Updated: Aug 8, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Organ-specific effects of DNA methylation by alkylating agents in the inbred Swiss mouse
Abstract:
Young adult inbred Swiss mice given single or repeated equitoxic doses of N-methyl-N-nitrosourea (MNUA) or methyl methanesulphonate (MMS) develop thymomas and pulmonary adenomas only following MNUA in spite of nearly identical overall alkylation of DNA of tumour target tissues by both agents due mainly to the biologically ineffective product 7-methylguanine. The main difference in DNA alkylation was the production of O6-methylguinine, a known pre-mutagenic product, by MNUA in amounts 10 or more times as large as following MMS. This supports the possibility that somatic mutations are a part of the process of carcinogenesis.
Insights
N-methyl-N-nitrosourea (MNUA) causes tumors in mice, unlike methyl methanesulphonate (MMS), despite similar DNA alkylation. This difference is linked to MNUA producing more pre-mutagenic O6-methylguanine, suggesting a role in carcinogenesis.
Area of Science:
- Toxicology
- Carcinogenesis
- Molecular Biology
Background:
- N-methyl-N-nitrosourea (MNUA) and methyl methanesulphonate (MMS) are alkylating agents with carcinogenic potential.
- Understanding differential DNA alkylation is crucial for elucidating mechanisms of chemical carcinogenesis.
Purpose of the Study:
- To investigate the differential DNA alkylation patterns induced by MNUA and MMS in mouse tumor target tissues.
- To correlate specific DNA adducts with tumor development following exposure to these agents.
Main Methods:
- Young adult inbred Swiss mice were administered single or repeated equitoxic doses of MNUA or MMS.
- DNA alkylation levels in tumor target tissues were analyzed.
- The types and quantities of DNA adducts, specifically 7-methylguanine and O6-methylguanine, were quantified.
Main Results:
- Both MNUA and MMS induced similar overall DNA alkylation, primarily through the formation of 7-methylguanine.
- Tumor development (thymomas and pulmonary adenomas) was observed only after MNUA administration.
- MNUA produced O6-methylguanine at levels 10-fold higher than MMS.
Conclusions:
- The formation of O6-methylguanine, a pre-mutagenic adduct, is a key factor differentiating the carcinogenic potential of MNUA and MMS.
- These findings support the hypothesis that somatic mutations, driven by specific DNA adducts, play a significant role in the process of carcinogenesis.
More Related Videos
07:50Immunohistochemical Detection of 5-Methylcytosine and 5-Hydroxymethylcytosine in Developing and Postmitotic Mouse Retina
Published on: August 29, 2018
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Related Concept Videos
Epigenetic Regulation
In-vitro Mutagenesis
Inheritance of Chromatin Structures
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Epigenetic Regulation
X-chromosome...